Intrinsic cells: Mesothelial cells - Central players in regulating inflammation and resolution

Peritoneal Dialysis International

Volumn 29, Issue SUPPL. 2, 2009, Pages

  Yung, Susan ^a   Chao, Tak Mao ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cytokines; Epithelial to mesenchymal transdifferentiation; Hyaluronan; Inflammation; Mesothelial cells; Proteoglycans

Indexed keywords

GLYCOSAMINOGLYCAN; HYALURONIC ACID; PROTEOGLYCAN; DIALYSIS FLUID;

CELL FUNCTION; CELL STRUCTURE; CELL TRANSPLANTATION; CONFERENCE PAPER; CYTOKINE PRODUCTION; FIBRINOLYSIS; HUMAN; IMMUNOREGULATION; MESOTHELIUM CELL; NONHUMAN; PERITONEAL DIALYSIS; PERITONEUM CELL; PERITONITIS; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; RISK FACTOR; ANIMAL; CELL DIFFERENTIATION; CHRONIC KIDNEY FAILURE; CONVALESCENCE; DRUG EFFECT; EPITHELIUM CELL; METABOLISM; PATHOLOGY; REVIEW;

ANIMALS; CELL DIFFERENTIATION; DIALYSIS SOLUTIONS; EPITHELIAL CELLS; GLYCOSAMINOGLYCANS; HUMANS; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; PERITONITIS; PROTEOGLYCANS; RECOVERY OF FUNCTION;

EID: 67449098531     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080902902s03     Document Type: Conference Paper

References (42)

1. Boulanger E, Wautier MP, Wautier JL, Boval B, Panis Y, Wernert N, et al. AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression. Kidney Int 2002; 61: 148-56.
2. Yáñez-Mó M, Lara-Pezzi E, Selgas R, Ramírez-Huesca M, Domínguez-Jiménez C, Jiménez-Heffernan JA, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003; 348:403-13.
3. Witowski J, Wisniewska J, Korybalska K, Bender TO, Breborowicz A, Gahl GM, et al. Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells. J Am Soc Nephrol 2001; 12:2434-41.
4. Mutsaers SE. Mesothelial cells: their structure, function and role in serosal repair. Respirology 2002; 7:171-91.
5. Yung S, Li FK, Chan TM. Peritoneal mesothelial cell culture and biology. Perit Dial Int 2006; 26:162-73.
6. Chan TM, Leung JK, Tsang RC, Liu ZH, Li LS, Yung S. Emodin ameliorates glucose-induced matrix synthesis in human peritoneal mesothelial cells. Kidney Int 2003; 64: 519-33.
7. Topley N, Brown Z, Jorres A, Westwick J, Davies M, Coles GA, et al. Human peritoneal mesothelial cells synthesize interleukin-8. Synergistic induction by interleukin-1 beta and tumor necrosis factor-α. Am J Pathol 1993; 142: 1876-86.
8. Topley N, Jörres A, Luttmann W, Petersen MM, Lang MJ, Thierauch KH, et al. Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1 β and TNF α. Kidney Int 1993; 43:226-33.
9. Lee HB, Yu MR, Song JS, Ha H. Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells. Kidney Int 2004; 65:1170-9.
10. Connell ND, Rheinwald JG. Regulation of the cytoskeleton in mesothelial cells: reversible loss of keratin and increase in vimentin during rapid growth in culture. Cell 1983; 34: 245-53.
11. Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD. Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 1990; 37:1563-70.
12. Nevado J, Vallejo S, El-Assar M, Peiro C, Sanchez-Ferrer CF, Rodriguez-Manas L. Changes in the human peritoneal mesothelial cells during aging. Kidney Int 2006; 69: 313-22.
13. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008; 454:428-35.
14. Lai KN, Tang SC, Leung JC. Mediators of inflammation and fibrosis. Perit Dial Int 2007; 27(Suppl 2):S65-71.
15. Witowski J, Bender TO, Gahl GM, Frei U, Jörres A. Glucose degradation products and peritoneal membrane function. Perit Dial Int 2001; 21:201-5.
16. Park JH, Kim YG, Shaw M, Kanneganti TD, Fujimoto Y, Fukase K, et al. Nod1/RICK and TLR signaling regulate chemokine and antimicrobial innate immune responses in mesothelial cells. J Immunol 2007; 179:514-21.
17. Tekstra J, Visser CE, Tuk CW, Brouwer-Steenbergen JJ, Burger CW, Krediet RT, et al. Identification of the major chemokines that regulate cell influxes in peritoneal dialysis patients. J Am Soc Nephrol 1996; 7:2379-84.
18. Betjes MG, Visser CE, Zemel D, Tuk CW, Struijk DG, Krediet RT, et al. Intraperitoneal interleukin-8 and neutrophilin-flux in the initial phase of a CAPD peritonitis. Perit Dial Int 1996; 16:385-92.
19. Kato S, Yuzawa Y, Tsuboi N, Maruyama S, Morita Y, Matsuguchi T, et al. Endotoxin-induced chemokine expression in murine peritoneal mesothelial cells: the role of toll-like receptor 4. J Am Soc Nephrol 2004; 15:1289-99.
20. Johnson Z, Power CA, Weiss C, Rintelen F, Ji H, Ruckle T, et al. Chemokine inhibition - why, when, where, which and how? Biochem Soc Trans 2004; 32:366-77.
21. Parish CR. The role of heparan sulphate in inflammation. Nat Rev Immunol 2006; 6:633-43.
22. Sadir R, Imberty A, Baleux F, Lortat-Jacob H. Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV. J Biol Chem 2004; 279:43854-60.
23. Li FK, Davenport A, Robson RL, Loetscher P, Rothlein R, Williams JD, et al. Leukocyte migration across human peritoneal mesothelial cells is dependent on directed chemokine secretion and ICAM-1 expression. Kidney Int 1998; 54:2170-83.
24. Yung S, Thomas GJ, Stylianou E, Williams JD, Coles GA, Davies M. Source of peritoneal proteoglycans. Human peritoneal mesothelial cells synthesize and secrete mainly small dermatan sulfate proteoglycans. Am J Pathol 1995; 146:520-9.
25. Yung S, Chen XR, Tsang RC, Zhang Q, Chan TM. Reduction of perlecan synthesis and induction of TGF-β1 in human peritoneal mesothelial cells due to high dialysate glucose concentration: implication in peritoneal dialysis. J Am Soc Nephrol 2004; 15:1178-88.
26. Yung S, Hausser H, Thomas G, Schaefer L, Kresse H, Davies M. Catabolism of newly synthesized decorin in vitro by human peritoneal mesothelial cells. Perit Dial Int 2004; 24:147-55.
27. Yung S, Chan TM. Peritoneal proteoglycans: much more than ground substance. Perit Dial Int 2007; 27:375-90.
28. Laurent TC, Fraser JR. Hyaluronan. FASEB J 1992; 6:2397-404.
29. Yung S, Coles GA, Davies M. IL-1 β, a major stimulator of hyaluronan synthesis in vitro of human peritoneal mesothelial cells: relevance to peritonitis in CAPD. Kidney Int 1996; 50:1337-43.
30. Yung S, Thomas GJ, Davies M. Induction of hyaluronan metabolism after mechanical injury of human peritoneal mesothelial cells in vitro. Kidney Int 2000; 58:1953-62.
31. Yung S, Chan TM. Hyaluronan - regulator and initiator of peritoneal inflammation and remodeling. Int J Artif Organs 2007; 30:477-83.
32. Selbi W, de la Motte CA, Hascall VC, Day AJ, Bowen T, Phillips AO. Characterization of hyaluronan cable structure and function in renal proximal tubular epithelial cells. Kidney Int 2006; 70:1287-95.
33. Haslinger B, Mandl-Weber S, Sellmayer A, Sitter T. Hyaluronan fragments induce the synthesis of MCP-1 and IL-8 in cultured human peritoneal mesothelial cells. Cell Tissue Res 2001; 305:79-86.
34. Szeto CC, Wong TY, Lai KB, Lam CW, Lai KN, Li PK. Dialy-sate hyaluronan concentration predicts survival but not peritoneal sclerosis in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 2000; 36:609-14.
35. Yung S, Davies M. Response of the human peritoneal mesothelial cell to injury: an in vitro model of peritoneal wound healing. Kidney Int 1998; 54:2160-9.
36. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13:470-9.
37. Williams JD, Craig KJ, Topley N, Williams GT. Peritoneal dialysis: changes to the structure of the peritoneal membrane and potential for biocompatible solutions. Kidney Int Suppl 2003; (84):S158-61.
38. Mutsaers SE, Prele CM, Lansley SM, Herrick SE. The origin of regenerating mesothelium: a historical perspective. Int J Artif Organs 2007; 30:484-94.
39. Mutsaers SE, Di Paolo N. Future directions in mesothelial transplantation research. Int J Artif Organs 2007; 30: 557-61.
40. Rougier JP, Guia S, Hagege J, Nguyen G, Ronco PM. PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: transcriptional regulation by TGF-β1. Kidney Int 1998; 54:87-98.
41. Hekking LH, Zweers MM, Keuning ED, Driesprong BA, de Waart DR, Beelen RH, et al. Apparent successful mesothelial cell transplantation hampered by peritoneal activation. Kidney Int 2005; 68:2362-7.
42. Hoff CM, Shockley TR. Peritoneal dialysis in the 21st century: the potential of gene therapy. J Am Soc Nephrol 2002; 13(Suppl 1):S117-24.